Quick Ratio (Acid-Test): 0.52
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.52 is 48% below its 5-year average of 0.99, near the low end of its 5-year range (0.37–1.86).
As of Saturday, June 27, 2026. 8.71% below its 12-month average of 0.57.
NRC Quick Ratio
Reported quarterly quick ratio; no daily interpolation.
NRC Average Quick Ratio (Acid-Test) Chart
NRC Current vs Average Quick Ratio (Acid-Test) Chart
NRC Quick Ratio (Acid-Test) Metrics
QUICK RATIO (ACID-TEST)
0.52
QUICK RATIO (ACID-TEST) AVG TTM
0.57
QUICK RATIO (ACID-TEST) AVG 3Y
0.54
QUICK RATIO (ACID-TEST) AVG 5Y
0.99
QUICK RATIO (ACID-TEST) AVG 10Y
1.07
QUICK RATIO (ACID-TEST) AVG 15Y
1.14
QUICK RATIO (ACID-TEST) AVG 20Y
1.05
CURRENT VS TTM AVG
-8.71%
CURRENT VS 3Y AVG
-3.46%
CURRENT VS 5Y AVG
-47.56%
CURRENT VS 10Y AVG
-51.45%
CURRENT VS 15Y AVG
-54.42%
CURRENT VS 20Y AVG
-50.73%
NRC Competitors' Quick Ratio (Acid-Test)
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| National Research Corporation (NRC) | $468.99M | 0.52 | 0.57 | 0.54 | 0.99 |
| Shoulder Innovations, Inc. (SI)vs › | $472.62M | -17.44 | 5.81 | 5.81 | 5.81 |
| 23andMe Holding Co. (ME)vs › | $15.31M | 0.70 | 1.29 | 2.30 | 2.23 |
| Teladoc Health, Inc. (TDOC)vs › | $1.51B | 2.59 | 2.16 | 2.71 | 2.89 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | 1.03 | 0.89 | 0.95 | 0.97 |
| TransMedics Group, Inc. (TMDX)vs › | $2.37B | 6.59 | 7.05 | 8.10 | 8.04 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.56B | 1.61 | 1.56 | 2.48 | 3.39 |
| Oscar Health, Inc. (OSCR)vs › | $7.72B | 0.95 | 0.93 | 1.04 | 1.20 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.13B | 4.19 | 4.52 | 4.42 | 3.69 |
| Universal Health Services, Inc. (UHS)vs › | $9.12B | 0.98 | 1.07 | 1.16 | 1.16 |
Liquidity Comparison
Quick Ratio
0.52
Excludes inventory
Current Ratio
0.55
Includes inventory
Quick Ratio (Acid-Test) Formula & Definition
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Quick Ratio (Acid-Test) FAQ
- What is the quick ratio (acid-test) for National Research Corporation (NRC)?
- The quick ratio (acid-test) for NRC stock is 0.52.
- Is National Research Corporation's quick ratio (acid-test) high or low?
- The quick ratio (acid-test) of 0.52 is 48% below its 5-year average of 0.99, near the low end of its 5-year range (0.37–1.86).
- What is the TTM average quick ratio (acid-test) for National Research Corporation (NRC)?
- The TTM average quick ratio (acid-test) for NRC stock is 0.57.
- What is the 3Y average quick ratio (acid-test) for National Research Corporation (NRC)?
- The 3Y average quick ratio (acid-test) for NRC stock is 0.54.
- What is the 5Y average quick ratio (acid-test) for National Research Corporation (NRC)?
- The 5Y average quick ratio (acid-test) for NRC stock is 0.99.
- What is the 10Y average quick ratio (acid-test) for National Research Corporation (NRC)?
- The 10Y average quick ratio (acid-test) for NRC stock is 1.07.
- What is the 15Y average quick ratio (acid-test) for National Research Corporation (NRC)?
- The 15Y average quick ratio (acid-test) for NRC stock is 1.14.
- What is the 20Y average quick ratio (acid-test) for National Research Corporation (NRC)?
- The 20Y average quick ratio (acid-test) for NRC stock is 1.05.
NRC Quick Ratio (Acid-Test) History
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-03-31 | 0.52 |
| 2025-12-31 | 0.55 |
| 2025-09-30 | 0.53 |
| 2025-06-30 | 0.70 |
| 2025-03-31 | 0.54 |
| 2024-12-31 | 0.55 |
| 2024-09-30 | 0.47 |
| 2024-06-30 | 0.37 |
| 2024-03-31 | 0.41 |
| 2023-12-31 | 0.67 |
| 2023-09-30 | 0.61 |
| 2023-06-30 | 1.21 |
| 2023-03-31 | 1.25 |
| 2022-12-31 | 1.31 |
| 2022-09-30 | 1.20 |
| 2022-06-30 | 1.31 |
| 2022-03-31 | 1.55 |
| 2021-12-31 | 1.82 |
| 2021-09-30 | 1.86 |
| 2021-06-30 | 1.69 |
| 2021-03-31 | 1.68 |
| 2020-12-31 | 1.71 |
| 2020-09-30 | 1.48 |
| 2020-06-30 | 1.14 |
| 2020-03-31 | 0.88 |
| 2019-12-31 | 0.76 |
| 2019-09-30 | 0.69 |
| 2019-06-30 | 0.54 |
| 2019-03-31 | 0.49 |
| 2018-12-31 | 0.60 |
| 2018-09-30 | 0.71 |
| 2018-06-30 | 0.58 |
| 2018-03-31 | 1.69 |
| 2017-12-31 | 1.62 |
| 2017-09-30 | 1.49 |
| 2017-06-30 | 1.54 |
| 2017-03-31 | 1.46 |
| 2016-12-31 | 1.49 |
| 2016-09-30 | 1.47 |
| 2016-06-30 | 1.40 |
| 2016-03-31 | 1.32 |
| 2015-12-31 | 1.27 |
| 2015-09-30 | 1.66 |
| 2015-06-30 | 1.82 |
| 2015-03-31 | 1.85 |
| 2014-12-31 | 1.90 |
| 2014-09-30 | 1.97 |
| 2014-06-30 | 1.81 |
| 2014-03-31 | 1.77 |
| 2013-12-31 | 1.54 |
| 2013-09-30 | 1.27 |
| 2013-06-30 | 1.12 |
| 2013-03-31 | 0.71 |
| 2012-12-31 | 0.67 |
| 2012-09-30 | 0.86 |
| 2012-06-30 | 1.12 |
| 2012-03-31 | 1.03 |
| 2011-12-31 | 0.91 |
| 2011-09-30 | 0.81 |
| 2011-06-30 | 0.77 |
| 2011-03-31 | 0.78 |
| 2010-12-31 | 0.53 |
| 2010-09-30 | 0.65 |
| 2010-06-30 | 0.94 |
| 2010-03-31 | 0.89 |
| 2009-12-31 | 0.55 |
| 2009-09-30 | 0.69 |
| 2009-06-30 | 0.58 |
| 2009-03-31 | 0.53 |
| 2008-12-31 | 0.43 |
| 2008-09-30 | 0.64 |
| 2008-06-30 | 0.60 |
| 2008-03-31 | 0.61 |
| 2007-12-31 | 0.84 |
| 2007-09-30 | 0.98 |
| 2007-06-30 | 0.97 |
| 2007-03-31 | 0.97 |
| 2006-12-31 | 0.90 |
| 2006-09-30 | 0.81 |
| 2006-06-30 | 0.77 |
| 2006-03-31 | 2.01 |
| 2005-12-31 | 1.79 |
| 2005-09-30 | 2.79 |
| 2005-06-30 | 2.75 |
| 2005-03-31 | 3.69 |
| 2004-12-31 | 4.02 |
| 2004-09-30 | 3.87 |
| 2004-06-30 | 2.99 |
| 2004-03-31 | 3.05 |
| 2003-12-31 | 3.38 |
| 2003-09-30 | 3.51 |
| 2003-06-30 | 2.75 |
| 2003-03-31 | 2.82 |
| 2002-12-31 | 3.48 |
| 2002-09-30 | 3.08 |
| 2002-06-30 | 2.45 |
Related Metrics
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green